Form 4: Inspire Medical Director Acquires Stock as Compensation

Inspire Medical Systems Director Casey M. Tansey acquired 181 shares of common stock in lieu of cash fees, increasing direct beneficial ownership to 22,416 shares.

Summary

• Casey M. Tansey, a Director of Inspire Medical Systems, Inc. (INSP), acquired 181 shares of common stock.
• The transaction occurred on January 15, 2026, at a price of $96.47 per share.
• These shares were received in lieu of cash fees, consistent with the Company's Non-Employee Director Compensation Policy.
• Following this transaction, Tansey directly beneficially owns 22,416 shares of common stock.
• Additionally, Tansey indirectly beneficially owns 500 shares through The Kimberly Tansey Irrevocable Trust and another 500 shares through The Kylie Tansey Irrevocable Trust.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially in lieu of cash compensation, generally signals confidence in the company's future performance and aligns management's interests with shareholders. This is a positive, albeit minor, indicator.

Positives

• A Director acquired shares, indicating alignment of interests with shareholders.
• The acquisition was part of a compensation policy, suggesting a structured approach to director remuneration.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

This is a standard insider transaction report and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The director's increased ownership aligns interests, potentially boosting investor confidence.
• Management: The compensation policy encourages directors to hold company stock.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction where a director received shares as part of their compensation. While it indicates alignment of interests, the transaction size is not significant enough to warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and evaluate the company based on its broader financial performance and strategic outlook.

Keywords

Inspire Medical Systems, INSP, Form 4, Insider Trading, Director Stock Acquisition, Equity Compensation, Beneficial Ownership